CPHI Milan 2026

CPHI Milan 2026

Meet us at CPHI Milan 2026

Symbiosis are exhibiting at CPHI Milan in October, one of the pharmaceutical industry’s most established global events.

Bringing together innovators, manufacturers and partners from across the drug development lifecycle, CPHI Milan offers the ideal opportunity to explore how the right CDMO partner can add value to your aseptic manufacturing programme. Whether you are advancing a clinical candidate or preparing for commercial manufacture, our team will be happy to discuss your requirements and explore how we can contribute to your goals.

Meet us at booth #12F70 and discover how Symbiosis can help accelerate your drug manufacturing programme.

_______________________________________

Why meet with Symbiosis?

As a specialist CDMO, Symbiosis provides GMP aseptic fill-finish for injectable biopharmaceuticals, supporting clients from clinical development through to commercial manufacture.

Meet with us to discuss:

  • Your manufacturing requirements and upcoming development plans
  • Clinical and commercial aseptic fill-finish for injectable products
  • Flexible manufacturing solutions aligned with your programme
  • Technical and regulatory considerations for sterile product manufacture
  • How an experienced CDMO partner can support your development timeline

 
We look forward to seeing you in Milan.

Request a meeting

Team at CPHI Milan 2026

Joanne Anderson, Chief Commercial Officer at Symbiosis Pharmaceutical Services
Joanne Anderson

Chief Commercial Officer

Jay Chima, Vice President, Business Development at Symbiosis Pharmaceutical Services
Jay Chima

Vice President, Business Development

Jos Vergeest, Senior Business Development Director at Symbiosis Pharmaceutical Services
Jos Vergeest

Senior Business Development Director

Roslyn Holmes, Business Development Manager at Symbiosis Pharmaceutical Services
Roslyn Holmes

Business Development Manager

Sign up to our newsletter and stay informed

Want to be the first to know about our latest capabilities and offerings? Subscribe for exclusive updates.